Related Experiment Video
Updated: Jun 13, 2025

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy
Published on: April 19, 2024
Operative Timing for Elective Thoracoscopic Lobectomy for CPAM and Sequestration: A NSQIP-Pediatric Analysis
John M Woodward1, Rhys Mendel2, Stephanie F Brierley1
1University at Buffalo Department of Surgery, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY 14215, USA; University at Buffalo Division of Pediatric Surgery, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY 14215, USA.
Background:
There is limited literature on optimal timing for elective thoracoscopic lobectomy for congenital pulmonary airway malformations (CPAM) and sequestration. Using NSQIP-P, we aim to assess optimal operative timing for elective thoracoscopic lobectomy for CPAM and sequestration.
Methods:
Data from the NSQIP-Pediatric registry was used to evaluate elective thoracoscopic lobectomy patients from 2017 to 2021 diagnosed with congenital pulmonary airway malformation or sequestration. Open lobectomy, ventilator dependent, oxygen dependent, and patients <1 month old were excluded. Clinical characteristics and outcomes were compared for age cohorts (in months): 1-3, 3-6, 6-9, 9-12, 12-24, and 24+.
Results:
There were 717 patients identified. Operative time significantly increased with age from 1 to 3 months to the 24+ month cohort (164.9 min-221.7 min, p = 0.014). Rates of conversion to open were 7.4% vs 21.8%, p = 0.181 in these age groups, respectively. Though not statistically significant, 14.8% of patients at 1-3 months had transfusion events reported compared to 6.4% at 3-6 months and 1.3% at 24+ months (p = 0.067). There were no significant differences between age groups for 30-day unplanned readmission, reoperation, non-transfusion complications, all complications, or mortality.
Conclusion:
Optimal surgical timing for thoracoscopic lobectomy for CPAM and sequestration is complex. Surgery at younger ages is associated with significantly shorter operative times; however, a greater powered study is needed to further assess the conversion to open rate in patients >3 months and the bleeding/transfusion rate in patients <3 months of age.
Level Of Evidence (I-V):
Level III.
More Related Videos
05:39Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
09:31Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism
Published on: February 14, 2022